Rituximab Therapy in Idiopathic Membranous Nephropathy

2010294 citationsJournal Articlegreen Open Access

Authors

Fernando C. Fervenza · Hypertension Institute

Roshini S. Abraham

Stephen B. Erickson · Hypertension Institute

María V. Irazabal · Hypertension Institute

Alfonso Eirin · Hypertension Institute

Ulrich Specks · Pulmonary and Critical Care Associates

Patrick H. Nachman · University of North Carolina at Chapel Hill

Abstract

Four doses of RTX resulted in more effective B cell depletion, but proteinuria reduction was similar to RTX at 1 g every 2 weeks. Baseline quantification of lymphocyte subpopulations did not predict response to RTX therapy.

Topics & Keywords

Renal Diseases and Glomerulopathies Immunodeficiency and Autoimmune Disorders Systemic Lupus Erythematosus Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Journal of the American Society of Nephrology

Volume 5, Issue 12, pp. 2188-2198

DOI: 10.2215/cjn.05080610

Field-Weighted Citation Impact: 9.47